Lead Researcher: Professor Jacqui Matthews
Institution: The University of Sydney (NSW)
Funding: $357,111
Funding Duration: 2014 - 2016
The Research
The oncoprotein LMO4 is a marker of poor prognosis in breast cancer. This work aims to develop inhibitors of LMO4 that will be used to establish the effectiveness of this protein as a drug target, and in the development of new therapeutics for this disease.
share
.svg)
